ArticleBMC cardiovascular disorders2026
Radiation exposure and fluoroscopy time in AVNRT ablation: role of 3D electroanatomical mapping.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrioventricular nodal reentrant tachycardia (AVNRT) is the most frequent regular supraventricular tachycardia in adults. Catheter ablation of the slow pathway is considered first-line therapy, offering high success with low complication risk. Conventional fluoroscopy-guided ablation, however, exposes both patients and operators to ionizing radiation. Three-dimensional (3D) electroanatomical mapping systems have emerged as a promising alternative to reduce radiation while maintaining efficacy.
methodsWe retrospectively reviewed 170 patients who underwent AVNRT ablation between June 2023 and August 2025. A total of 112 patients were treated using conventional fluoroscopy guidance, and 58 patients underwent 3D mapping-guided ablation. Radiation exposure, fluoroscopy time, procedural outcomes, and complications were compared between groups.
resultsRadiation dose, assessed by dose–area product (DAP), was significantly higher in the conventional group (3613.6 ± 1202 mGy·cm²) than in the 3D group (656 ± 189 mGy·cm², p < 0.05). Fluoroscopy time was likewise longer in the conventional group (638 ± 161 s vs. 291.6 ± 52.6 s, p < 0.05). Acute success was 98.2% in the conventional group and 100% in the 3D group. Two patients in the conventional group developed permanent atrioventricular block requiring pacemaker implantation, while one recurrence and one procedural failure were also recorded. In the 3D group, one patient experienced transient atrioventricular block requiring temporary pacing, with no recurrences.
conclusionThree-dimensional mapping significantly reduces radiation exposure without compromising safety or efficacy in AVNRT ablation. Adoption of this approach may enhance patient and operator safety in routine practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.